Navigation Links
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
Date:2/19/2008

Pamela Harris appointed to lead Diabetes Sales, Managed Care and Government

Accounts on national level

PRINCETON, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Novo Nordisk, a healthcare company with an 85-year history of innovation and achievement in diabetes care, today announced the company has appointed Pamela Harris as vice president for Diabetes Sales, Managed Care and Government Accounts, effective immediately.

Harris, who since 2005 shared responsibility for managing the diabetes field force, will assume an expanded role of leading the company's 2,000-person field organization of representatives and managed market account executives.

"Pam has developed an impressive and successful track record in sales, managed healthcare, training and marketing," said Jerzy Gruhn, president of Novo Nordisk, Inc. "Her leadership style and strong business experience will help us continue to grow our company and help change the lives of millions of people living with diabetes."

Harris joined Novo Nordisk in 2005 after leading one of the national sales teams at Novartis Pharmaceuticals. In her 28 years in the pharmaceutical industry, she has held various positions in sales leadership roles, training, and marketing. Harris has received several awards recognizing her achievements. At Bristol-Myers Squibb, she was recognized for outstanding leadership and selected from 800 nominees worldwide to receive the Bristol-Myers Squibb Leadership Development Award. Additionally, she has been honored by the Harlem YWCA and was the recipient of their Black Achiever in Industry Award.

Harris received a Bachelor's degree from the College of New Jersey (formerly Trenton State College).

About Novo Nordisk

Novo Nordisk is a healthcare company with an 85-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 26,000 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Novo Nordisk Appoints New Leader of North American Business
2. Novo Nordisk Ranks Supersector Leader in the 2007 Dow Jones Sustainability Indexes
3. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
4. Novo Nordisk Increased Net Profit by 32% in 2007
5. Novo Nordisk Files Annual Report with the SEC
6. Adverse housing conditions contribute to diabetes risk
7. RAND finds cases of undiagnosed diabetes drop sharply
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Diabetes appears to increase risk of death for patients with acute coronary syndromes
10. Discovery of sugar sensor in intestine could benefit diabetes
11. Despite overeating, morbidly obese mice gain protection against diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: